Pro 2013-007 (Announcement of Jianfeng Group on Providing Counter-Guarantees to Corporate Bond Counter-Guarantors)
Release time:
2020-08-05
证券代码:600668 证券简称:尖峰集团 编号:临2013-007
浙江尖峰集团股份有限公司
关于向公司债券反担保人提供反担保的公告
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
重要内容提示:
l本次担保的被担保人(质押权人)名称:天津帝士力投资控股集团有限公司
l本次担保金额:公司拟发行的规模不超过6亿元公司债券的本金及利息
l本次担保是否有反担保:本次对外担保实质是为公司发行公司债进行反担保
l对外担保逾期的累计数量:无
一、担保情况概述
2013年1月22日,公司召开的2013年第一次临时股东大会已批准关于公司发行票面总额不超过6亿元、期限不超过7年的公司债的相关议案,并授权董事会根据市场情况确定本次公司债券是否采用担保及具体担保方式,授权董事会及其授权人士(董事长、董事会秘书)全权办理本次发行公司债券相关事项。详见本公司2013年1月5日披露的《第八届董事会第八次会议决议公告》、《关于发行公司债券方案的公告》和2013年1月23日披露的《2013年第一次临时股东大会决议公告》,上述公告分别披露在《上海证券报》、《中国证券报》和上海证券交易所网站(http://www.sse.com.cn)上。
2013年2月26日,浙江尖峰集团股份有限公司以通信方式召开了第八届第九次董事会,公司现有董事9名,全部出席了本次会议,关联董事蒋晓萌先生、杜自弘先生回避了部分议案的表决,符合《公司法》和《公司章程》的有关规定,所做决议合法有效。经审议与表决,董事会以7票同意、0票反对、0票弃权审议通过了《关于向公司债券反担保人提供反担保的议案》。
为增强本次公司债的偿债保障,降低发行利率,本公司确定由天津天士力集团有限公司(以下简称:天士力集团)为本次公司债提供全额无条件的不可撤销的连带责任保证担保;由天士力集团的大股东天津帝士力投资控股集团有限公司(以下简称:帝士力控股)为天士力集团在该担保责任范围内提供保证方式的反担保。
由本公司将所持有的天士力集团20.76%股权质押给本次公司债券反担保人帝士力控股,作为本公司向帝士力控股在其担保责任范围内提供的反担保。授权公司董事长签署与上述担保及反担保相关的所有法律文件。
本次股权质押的质权人帝士力控股与本公司不存在关联关系;因本公司董事蒋晓萌先生和杜自弘先生也同时担任天士力集团的董事,根据上海证券交易所《股票上市规则》的相关规定,天士力集团是本公司的关联方。
二、被担保人(质押权人)基本情况
1、被担保人(质押权人)名称:天津帝士力投资控股集团有限公司。
2、成立时间: 1998年11月12日。
3、住所:天津北辰科技园区。
4、法定代表人:闫希军。
5、注册资本:3500万元。
6、经营范围:技术开发、咨询、服务、转让生物技术及产品,以自有资金对保健食品、高科技行业进行投资。
7、与本公司关系:帝士力控股为本公司联营公司天士力集团的第一大股东,与本公司不存在关联关系。
8、财务情况:
按经审计的合并财务报表口径,截至2011年末,帝士力控股资产总额1,110,405.48万元,负债总额683,441.77万元,所有者权益合计(含少数股东权益)426,963.71万元。2011年度,实现营业收入978,075.32万元,净利润(含少数股东权益)31,842.31万元。
按未经审计的合并财务报表口径,截至2012年三季度末,帝士力控股资产总额1,135,037.33万元,负债总额663,027.71万元,所有者权益合计(含少数股东权益)472,009.62万元;2012年1-9月,实现营业收入730,728.46万元,净利润(含少数股东权益)56,912.14万元。
三、股权质押反担保的主要内容
(一)股权质押反担保内容
天士力集团为本公司拟发行的票面总额不超过6亿元、期限不超过7年的公司债提供全额无条件不可撤消的连带责任保证担保。由帝士力控股为天士力集团在该担保责任范围内提供保证方式的反担保。
本公司将所持有的天士力集团20.76%股权质押给帝士力控股,作为本公司向帝士力控股在其担保责任范围内提供的反担保。
(二)用于设定质押的反担保资产情况
公司本次用于反担保的质押资产是所持有的天士力集团20.76%股权,截止2011年末,该部分股权的投资成本为5,067.34万元。
1、天士力集团成立于2000年3月30日,注册地址:天津北辰科技园区,现有注册资本:23,784.38万元,其中:帝士力控股占61.68%、本公司占20.76%。经营范围:对外投资、控股;天然植物药种植及相关加工、分离;组织所属企业开展产品的生产、科研、销售、进出口经营业务;各类商品、物资的批发、零售;技术开发、咨询、服务、转让生物技术(不含药品生产与销售)及产品等。天士力集团是以大健康产业为主线,以制药业为中心,集生产、投资于一体的多元化集团企业。截止2012年9月末,天士力集团持有上市公司天士力制药集团股份有限公司47.27%的股权。
2、用于设定质押的反担保资产账面价值:截至2011年12月31日,反担保资产经审计的长期股权投资帐面价值35,239.73万元。截至2012年9月30日,反担保资产未经审计的长期股权投资帐面价值46,012.89万元。
3、用于设定质押的反担保资产在用于本次质押前不存在质押或者其他第三人权利、不涉及诉讼、仲裁事项,不存在查封、冻结等司法措施等情形以及妨碍权属转移的其他情况。
4、天士力集团2011年度财务报告经具从事证券、期货业务资格的天健会计师事务所(特殊普通合伙)审计,并出具标准无保留意见的审计报告。截至2011年12月31日,天士力集团经审计的合并口径资产总额1,041,815.88万元,负债总额634,383.72万元,归属于母公司所有者权益合计169,366.60万元。2011年度,实现主营业务收入927,977.29万元,利润总额86,209.96万元,归属于母公司所有者的净利润24,656.61万元。
截至2012年9月末,天士力集团未经审计的合并口径资产总额1,090,843.81万元,负债总额612,510.59万元,归属于母公司所有者权益合计221,974.93万元。2012年1-9月,实现主营业务收入694,726.89万元,利润总额104,716.12万元,归属于母公司所有者的净利润56,550.32万元。
四、董事会意见
1、股权质押反担保的必要性
由天士力集团为本次公司债券提供担保能切实增强公司债的偿债保障,有利于降低债券发行成本。帝士力控股向天士力集团提供保证方式的反担保,同时本公司对帝士力控股提供股权质押方式的反担保,是本次公司债券担保方案的组成部分,已经2013年第一次临时股东大会决议授权。上述反担保措施符合本公司及股东的整体利益。
2、股权质押反担保风险
由帝士力控股向天士力集团提供保证方式的反担保, 本公司向帝士力控股提供股权质押方式的反担保,实质是为本公司自身的融资进行担保。只要本公司能够按期偿还公司债券的本息,本次股权质押反担保的风险很小,不会影响公司经营。
五、累计对外担保数量及逾期担保的数量
截止本公告披露日,公司及其控股子公司已批准的对外担保总额为7,000.00万元,占公司2011年经审计的合并口径归属于母公司所有者权益合计的4.93%;公司对控股子公司已批准的担保总额为73,000.00万元,占公司2011年经审计的合并口径归属于母公司所有者权益合计的51.40%。
截止本公告披露日,公司及其控股子公司对外担保实际余额为7,000.00万元,占公司2011年经审计的合并口径归属于母公司所有者权益合计的4.93%;公司对控股子公司的担保实际余额为18,481.00万元,占公司2011年经审计的合并口径归属于母公司所有者权益合计的13.01%。
截止本公告披露日,本公司没有逾期担保。
特此公告
浙江尖峰集团股份有限公司董事会
二〇一三年二月二十六日
More information
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-30
Peak Pharmaceutical Becomes National Intellectual Property Demonstration Enterprise
Just one year after it was identified as a national intellectual property advantage enterprise in 2016, "Zhejiang Jianfeng Pharmaceutical Co., Ltd." appeared in the list of national intellectual property demonstration enterprises in 2017 recently announced by the State Intellectual Property Office. As a result, Jianfeng Pharmaceutical has become the first and only national intellectual property demonstration enterprise in Jinhua City. On December 12, the State Intellectual Property Office issued a notice to announce the list of national intellectual property demonstration enterprises and advantageous enterprises in 2017. After the enterprise declaration, the recommendation of the provincial and municipal bureaus, the review of the national bureau, and the public announcement, 182 national intellectual property demonstration enterprises and 816 national intellectual property advantage enterprises have been identified. Including Jianfeng Pharmaceutical, Zhejiang Province has been identified as only 15 national intellectual property demonstration enterprises. With the continuous development of enterprises in recent years, Jianfeng Pharmaceutical has set up a special working organization to cultivate and improve the intellectual property ability from the aspects of strategic management, creation, operation and protection of intellectual property rights. It has successively compiled and implemented 27 procedural documents and 36 forms such as "Intellectual Property Management Manual", "Intellectual Property Reward and Punishment System" and "Trade Secret Management System, and timely according to the policy, the current situation of the enterprise to revise, in order to ensure the compliance and effectiveness of the operation of the system. In 2012 and 2013, Jianfeng Pharmaceutical was successively rated as a patent demonstration enterprise in Jinhua City and Zhejiang Province; in 2013, it won the third prize of Jinhua Patent Implementation Award; in 2016, it passed the certification of intellectual property management system and was identified as a national intellectual property advantage enterprise. Currently, Peak Pharmaceuticals has
2020
07-31
Jianfeng Pharmaceutical Approved to Set up Provincial Research Institute
A few days ago, the relevant departments of Zhejiang Province approved the establishment of the provincial research institute of the peak pharmaceutical company. This is another honor won by Jianfeng Pharmaceutical in the field of independent research and development and scientific and technological innovation after the national postdoctoral research workstation and Zhejiang academician expert workstation. The provincial enterprise research institute is a high-level R & D institution led by the Provincial Department of Science and Technology, jointly recognized by the Provincial Economic and Information Commission and the Provincial Development and Reform Commission. As an important part of the national technological innovation system, the Enterprise Research Institute is the core force of the innovation-driven development of Jianfeng Pharmaceutical, which reflects the ability of Jianfeng Pharmaceutical to set up higher-level and higher-level R & D institutions on its own. the ability to gather and integrate innovation elements, organize scientific and technological innovation, support the sustainable development of enterprises, and lead the technological progress of the industry. As a pharmaceutical enterprise, scientific and technological innovation is the eternal theme of enterprise development, and talent is the key to scientific and technological innovation. Over the years, Jianfeng Pharmaceutical has not only focused on cultivating its own scientific research talents, but also established close cooperative relations with well-known universities and scientific research institutions such as China Pharmaceutical University, Shenyang Pharmaceutical University, Sichuan Antibiotic Industry Research Institute, and also focused on introducing top think tanks. In 2011, Professor Liu Jiajian and his team from Sichuan Institute of Antibiotic Industry were introduced, focusing on the technical research of key intermediates of methoxy cephalosporin. In 2013, Professor Shan Weiguang and his scientific research team from Zhejiang University of Technology were introduced to carry out research on preparation technology. In 2015, Professor Wang Guangji, academician of the Chinese Academy of Engineering, was hired as the chief scientist to organize the research on the anti-drug resistance mechanism of national class I new drugs by intracellular pharmacokinetics. In 2017 with Shanghai antibody
2020
07-31
On November 16, the company held the first extraordinary general meeting of shareholders in 2017, which deliberated and passed the proposal on the expiration of the term of the board of directors and the proposal on the expiration of the term of the board of supervisors, and elected a new board of directors and the board of supervisors. The meeting used a combination of on-site registered voting and online voting to vote on director candidates one by one, and elected Jiang Xiaomeng, Du Zihong, Yu Jianhong, Huang Sujian, Liu Bo, Zhang Guoping, Huang Conyun, Sun Hongbin, and Shi Ximin as the company's tenth board of directors. Directors, of which Huang Conyun, Sun Hongbin, and Shi Ximin are independent directors. The meeting used a combination of on-site registered voting and online voting to vote on supervisor candidates one by one, and elected Chen Tianci, Lu Ruimei, and Shi Fu as supervisors of the company's ninth board of supervisors. Prior to this, the company's trade union held an enlarged meeting of the trade union committee to elect Qin Xuping and Jin Huazhong as employee representative supervisors of the ninth board of supervisors. On the same day, the company's tenth board of directors held its first meeting and elected Jiang Xiaomeng as the chairman of the tenth board of directors. Jiang Xiaomeng, Du Zihong, Huang Sujian, Sun Hongbin and Shi Ximin were elected as members of the Strategy Committee of the 10th Board of Directors, and Jiang Xiaomeng was the chairman of the Strategy Committee. Shi Ximin, Huang Conyun and Jiang Xiaomeng were elected as members of the audit committee of the 10th board of directors, and Shi Ximin was the chairman. Sun Hongbin, Huang Conyun and Jiang Xiaomeng were elected as members of the nomination committee of the 10th board of directors, and Sun Hongbin was the chairman. Huang Cong Yun, Shi Ximin and Du Zihong were elected as members of the remuneration and assessment committee of the 10th board of directors, and Huang Cong Yun was the chairman. The board of directors appointed Yu Jianhong as the general manager of the company and appointed Huang Jinlong.
2020
07-31
Peak natural products pollution control results by the industry attention
As a leader in China's plant extracts industry, Tianjin Jianfeng Natural Products Company has achieved fruitful results in technological innovation. On October 26 and 27, at the 2017 Forum on improving the international competitiveness of China's plant extract industry held in Handan City, Hebei Province, Liu Dan, general manager of the company, delivered a speech entitled "prevention and control of water pollution in the field of plant extraction", introducing the successful experience of sewage treatment in the past five years, which was widely concerned by the participants. In recent years, environmental protection and ecology have become hot words for the development of enterprises and society. Due to the particularity of the plant extraction industry, pollution control in this industry has different characteristics and requirements from ordinary production enterprises. For example, sewage presents higher chroma, extremely low PH value, more suspended solids, high salinity, high concentration of COD, and different sewage water quality of different products. As the earliest enterprise producing opc grape seed extract in China, Natural Products Company has always attached great importance to the pollution control of plant extraction. For example, in the sewage treatment upgrading project implemented in 2016, ozone oxidation and biochemical methods were adopted to remove the remaining organic pollutants, increasing the sewage treatment capacity from 200 cubic meters per day to 500 cubic meters. The latest anaerobic sewage treatment technology is adopted, the COD emission value of the outlet is reduced to 60 mg per liter, which is far lower than the national first-class emission standard of 100 mg per liter. The new system adopts advanced oxidation reaction tower, ozonation method, field energy reactor and sludge adsorption reflux technology, which can quickly and efficiently treat organic pollutants with strong chemical stability without adding any chemicals.
2020
07-31